The coordinated activation of PI3K/AKT and NF-κB Signaling can drive the malignant progression of multiple tumors including CRC (Ahmad et al. 2013), and these pathways are important targets for anti-cancer therapy. The gene discussed is AKT1; the disease is colorectal carcinoma.